Barentz announces new distribution agreement for Ashland pharmaceutical and nutraceutical products

Published: 17-Oct-2023

Barentz has signed a distribution agreement with Ashland that covers its portfolio of pharmaceutical and nutraceutical products in Ireland, UK, Denmark, Sweden, Norway, Finland, Iceland, Estonia, Latvia and Lithuania (effective 1 November)

Barentz is currently the distributor for Ashland pharmaceutical and nutraceutical products in Belgium, the Netherlands, Poland, Slovakia and the Czech Republic.

“For more than two decades, Ashland and Barentz have been building a partnership focused on life science markets. We look forward to leveraging Barentz’ experience with the Ashland pharmaceutical and nutraceutical portfolio,” said Tomas Navarro, Ashland General Manager Life Sciences EMEA.

“Our immediate focus is to transfer the technical and commercial knowledge to Barentz to support the current and future needs of our customers.”

“We are very pleased to now offer Ashland’s extensive and high-quality product portfolio to our pharma and nutra customers across an increasing number of countries in Europe,” said Anthony Litchfield, Global Vice President of Pharmaceutical Division at Barentz.

“We see it as an important new phase in our key strategic alliance with Ashland.”

You may also like